Plus Therapeutics, Inc.
PSTV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $73,449 | $16,830 | $13,840 | $9,045 |
| - Cash | $13,289 | $2,233 | $9,867 | $76 |
| + Debt | $21 | $30 | $40 | $3,367 |
| Enterprise Value | $60,181 | $14,627 | $4,013 | $12,336 |
| Revenue | $1,397 | $1,390 | $1,059 | $1,412 |
| % Growth | 0.5% | 31.3% | -25% | – |
| Gross Profit | $1,311 | $1,304 | $878 | $1,180 |
| % Margin | 93.8% | 93.8% | 82.9% | 83.6% |
| EBITDA | -$4,337 | $5,272 | -$13,461 | -$3,614 |
| % Margin | -310.5% | 379.3% | -1,271.1% | -255.9% |
| Net Income | -$4,423 | $5,151 | -$17,401 | -$3,903 |
| % Margin | -316.6% | 370.6% | -1,643.2% | -276.4% |
| EPS Diluted | -0.04 | -0.007 | -1.19 | -0.66 |
| % Growth | -515.4% | 99.5% | -80.3% | – |
| Operating Cash Flow | -$2,548 | -$5,798 | -$6,172 | -$1,211 |
| Capital Expenditures | -$27 | -$7 | -$3 | -$11 |
| Free Cash Flow | -$2,575 | -$5,805 | -$6,175 | -$1,222 |